Schizophrenia
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
2872
|
2897
|
0.420 |
None |
1.000 |
3 |
1
|
2009 |
2020 |
High density lipoprotein measurement
|
phenotype |
|
Laboratory Procedure
|
545
|
1440
|
0.100 |
None |
1.000 |
39 |
48
|
2008 |
2019 |
Triglycerides measurement
|
phenotype |
|
Laboratory Procedure
|
563
|
1418
|
0.100 |
None |
1.000 |
17 |
29
|
2008 |
2019 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.040 |
None |
1.000 |
4 |
|
2005 |
2019 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.110 |
None |
1.000 |
2 |
1
|
2016 |
2019 |
Moyamoya disease 1
|
disease |
Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
92
|
50
|
0.020 |
None |
1.000 |
2 |
|
2015 |
2019 |
Moyamoya Disease
|
disease |
Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
117
|
50
|
0.020 |
None |
1.000 |
2 |
|
2015 |
2019 |
Alzheimer's Disease
|
disease |
Nervous System Diseases; Mental Disorders
|
Disease or Syndrome
|
3397
|
1843
|
0.110 |
None |
1.000 |
2 |
2
|
2004 |
2019 |
Carcinoma, Ovarian Epithelial
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
2841
|
327
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2019 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Malignant neoplasm of ovary
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
2563
|
315
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Red Blood Cell Count measurement
|
phenotype |
|
Laboratory Procedure
|
717
|
1599
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
ovarian neoplasm
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
2542
|
757
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Alcohol consumption
|
phenotype |
Behavior and Behavior Mechanisms
|
Individual Behavior
|
210
|
535
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
White Blood Cell Count procedure
|
phenotype |
|
Laboratory Procedure
|
681
|
1322
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Adrenal Cortical Adenoma
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
156
|
9
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Leishmaniasis
|
disease |
Infections; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
198
|
4
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Tuberculosis
|
disease |
Infections
|
Disease or Syndrome
|
1256
|
328
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Liver carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
5725
|
942
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Glycine measurement
|
phenotype |
|
Laboratory Procedure
|
32
|
68
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Graft-vs-Host Disease
|
disease |
Immune System Diseases
|
Disease or Syndrome
|
447
|
25
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Serum total cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
486
|
1243
|
0.100 |
None |
1.000 |
14 |
29
|
2009 |
2018 |
Metabolic Syndrome X
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
1125
|
591
|
0.100 |
None |
1.000 |
4 |
8
|
2011 |
2018 |
Barrett Esophagus
|
disease |
Digestive System Diseases; Neoplasms
|
Disease or Syndrome
|
478
|
60
|
0.120 |
None |
0.750 |
4 |
3
|
2013 |
2018 |
Neural Tube Defects
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Congenital Abnormality
|
304
|
122
|
0.030 |
None |
1.000 |
3 |
|
2005 |
2018 |